rs78311289
|
|
G |
0.890 |
CausalMutation |
CLINVAR |
|
|
|
rs121913105
|
|
T |
0.730 |
CausalMutation |
CLINVAR |
|
|
|
rs121913105
|
|
C |
0.730 |
CausalMutation |
CLINVAR |
|
|
|
rs121913101
|
|
G |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs121913101
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs121913101
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs121913103
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs121913103
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs121913103
|
|
G |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs121913479
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs121913482
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs121913483
|
|
G |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs121913484
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs121913485
|
|
G |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs28931614
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs28933068
|
|
G |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs397515514
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs4647924
|
|
G |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs78311289
|
|
|
0.890 |
GeneticVariation |
UNIPROT |
Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3.
|
7773297 |
1995 |
rs78311289
|
|
|
0.890 |
GeneticVariation |
UNIPROT |
Thanatophoric dysplasia type II (TDII) is a neonatal lethal skeletal dysplasia caused by a recurrent Lys-650-->Glu mutation within the highly conserved activation loop of the kinase domain of fibroblast growth factor receptor 3 (FGFR3).
|
8754806 |
1996 |
rs78311289
|
|
|
0.890 |
GeneticVariation |
BEFREE |
Thanatophoric dysplasia type II (TDII) is a neonatal lethal skeletal dysplasia caused by a recurrent Lys-650-->Glu mutation within the highly conserved activation loop of the kinase domain of fibroblast growth factor receptor 3 (FGFR3).
|
8754806 |
1996 |
rs78311289
|
|
|
0.890 |
GeneticVariation |
BEFREE |
Despite its location within the same FGFR3 codon as the thanatophoric dysplasia type II mutation (Lys650Glu) and a similar effect on constitutive activation of the FGFR3 tyrosine kinase, the Lys650Met is not associated with cloverleaf skull or craniosynostosis.
|
10377013 |
1999 |
rs121913105
|
|
|
0.730 |
GeneticVariation |
BEFREE |
Despite its location within the same FGFR3 codon as the thanatophoric dysplasia type II mutation (Lys650Glu) and a similar effect on constitutive activation of the FGFR3 tyrosine kinase, the Lys650Met is not associated with cloverleaf skull or craniosynostosis.
|
10377013 |
1999 |
rs78311289
|
|
|
0.890 |
GeneticVariation |
BEFREE |
Mutation of Lys650-->Glu in the activation loop of the FGFR3 kinase domain causes the lethal human skeletal disorder thanatophoric dysplasia type II (TDII) and is also found in patients with multiple myeloma, bladder and cervical carcinomas.
|
10918587 |
2000 |
rs78311289
|
|
|
0.890 |
GeneticVariation |
BEFREE |
Two missense mutations in this codon are known to result in strong constitutive activation of the FGFR3 tyrosine kinase and cause three different skeletal dysplasia syndromes-thanatophoric dysplasia type II (TD2) (A1948G [Lys650Glu]) and SADDAN (severe achondroplasia with developmental delay and acanthosis nigricans) syndrome and thanatophoric dysplasia type I (TD1) (both due to A1949T [Lys650Met]).
|
11055896 |
2000 |